Galapagos NV GXE-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 9:08 AM CET
68.66quote price arrow down-0.84 (-1.21%)
52 week range
65.50 - 212.10

...

Loading . . .

KEY STATS

  • Open68.66
  • Day High68.66
  • Day Low68.66
  • Prev Close69.50
  • 52 Week High212.10
  • 52 Week High Date05/12/20
  • 52 Week Low65.50
  • 52 Week Low Date02/16/21
  • Market Cap5,407.98M
  • Shares Out65.41M
  • 10 Day Average Volume1,726.8
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-62.31

RATIOS/PROFITABILITY

  • EPS (TTM)-4.78
  • P/E (TTM)-14.36
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

QUOTE FINDER

Profile

MORE
Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is focused on the discovery and development of small molecule medicines with novel modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and other indications. The Company aims to develop a portfolio of clinical-stage therapies for the enhancement of existing treatment paradigms. In...
Raj Parekh
Non-Executive Chairman
Bart Filius
Chief Financial Officer
Address
Generaal De Wittelaan 3
Malines (mechelen)
2800
Belgium